Trypanosoma cruzi Dihydrolipoamide Dehydrogenase as Target for Phenothiazine Cationic Radicals. Effect of Antioxidants

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|7|9|1155-1179

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.9, 2006-09, pp. : 1155-1179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Major Cysteine Proteinase of Trypanosoma cruzi: A Valid Target for Chemotherapy of Chagas Disease

By  

Current Pharmaceutical Design, Vol. 7, Iss. 12, 2001-08 ,pp. : 1143-1156

Bentham Science Publishers

Access to resources Recommend Favorite

Kinetic and Crystallographic Studies on Glyceraldehyde-3-Phosphate Dehydrogenase from Trypanosoma cruzi in Complex with Iodoacetate

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 3, 2009-04 ,pp. : 210-214

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy of Trypanosoma Cruzi Infections

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 3, 2002-10 ,pp. : 247-254

Bentham Science Publishers

Access to resources Recommend Favorite

The Uniqueness of the Trypanosoma cruzi Mitochondrion: Opportunities to Target New Drugs Against Chagas' Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 20, 2011-07 ,pp. : 2074-2099

Bentham Science Publishers

Access to resources Recommend Favorite

Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi

By  

Current Medicinal Chemistry, Vol. 22, Iss. 18, 2015-06 ,pp. : 2225-2235

Bentham Science Publishers

Access to resources Recommend Favorite